Case study of data migration: a nightmare or a real need in 2025?

• Partnering for Transformation – SOLTI chose Flex Databases to address the limitations of their previous CTMS and improve operational efficiency.
• Migration Process – The transition managed through structured planning, tailored configuration, and consistent communication between both teams.
• Operational Improvements – Enhanced reporting, adaptable dashboards, and better oversight of monitoring activities supported by a more intuitive system.
• Key Takeaways – SOLTI’s experience highlights how a well-managed migration can strengthen trial management and prepare organizations for future growth

 

Clinical trial authorisations processes and practices in Europe

  •             Key steps and requirements for obtaining trial authorisation in the EU
  •             Comparing regulatory frameworks and timelines across regions
  •             Managing workload and compliance with limited resources
  •             When and why to outsource submissions
  •             Best practices and tips from experience for efficient submissions

Improving clinical trial execution through data insights

• Leveraging data to inform early protocol design and feasibility
• Identifying optimal countries and investigator networks through data-led geographic analysis
• Benchmarking expected timelines, enrollment performance and cost parameters
• Enhancing site selection and feasibility assessment using integrated datasets and e-feasibility tools
• Applying real-time data monitoring to detect risks and inform mid-trial decision-making

 

PANEL DISCUSSION Comparing the all-in-one CRO model to specialized CRO models in clinical development

  • Analyzing the efficiency and cost benefits of an all-in-one CRO versus using specialized CROs for different phases
  • Evaluating the flexibility of a multi-CRO model in adapting to diverse project needs and expertise
  • Weighing the risks of relying on a single provider versus the coordination challenges of managing multiple vendors
  • Considering the impact on communication, data integration, and consistency when using a single CRO compared to multiple CROs
  • Discussing the potential for innovation and quality improvements with specialized CROs versus the streamlined approach of an all-in-one model

Moderator

Marie Rasoanandrasana, Head, Supply Chain and Vendor Management, Debiopharm

Balancing in-house expertise and outsourcing for trial success

  • Comparing in-house and outsourced models for clinical trial execution
  • Evaluating decision-making frameworks for choosing the right resourcing strategy
  • Identifying key benefits and trade-offs in quality, speed, and flexibility
  • Exploring hybrid models and integrating CROs or FSPs effectively
  • Adapting operational approaches based on trial complexity, indication, and geography